Expected Revenue Growth:
The chiral chromatography column marketsize is projected to reach USD 123 million by 2025 from an estimated USD 99 millionin 2020, at a CAGR of4.5% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of the market. Moreover, growth opportunities in emerging countries as well asthe emergence of green chemistry,is likely to provide opportunities forthe chiral chromatography column industry.
Global Industry Segmentation:
The pharmaceutical&biotechnology companies end-usersegment is expected to grow at the highest CAGR from 2020 to 2025.
Pharmaceutical and biotechnology companies are among the key end-users of chiral chromatography columns.Increasing R&D for therapeutic areas, such as cancer, HIV/AIDS, and immunodeficiency disorders, technological innovations in biotechnology research, increasing focus of pharmaceutical and biotechnology companies on extending their product pipeline, rising number of drug discovery and clinical trial projects, and patent expiry of blockbuster drugs and biomolecules are some of the key factors driving the growth of this segment during the forecast period. Additionally, the availability of government and corporate funding for biotechnology and pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are other key factors driving the growth of this segment.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435
The metal based segment is expected to grow at the highest CAGR in the chiral chromatography column industry during the forecast period.
The increasing use of HPLC columns in academic institutes as well as in industries where high pressure is employed is likely to drive the market for stainless steel columns in the coming years. Agilent offers the SEC-5 HPLC columns packed with silica particles and coated with a neutral hydrophilic layer, which decreases sample-column interactions and improves peak capacity and resolution. Other prominent players in this market include Thermo Fisher Scientific, Inc., and Merck KGaA.Therefore, the high demand of metal-based columns in the pharmaceutical industry isexpected to emerge as key revenue pockets for the metal-based columns in the chiral chromatography column market.
The prepacked column is expected to grow at the highest CAGR during the forecast period.
Prepacked/ready-to-use columns are prefilled with the stationary phase and can directly be attached to chromatographic systems. Prepacked columns exhibit minimal variations and are uniform in nature. These columns are used for early method development for optimizing column packing. These columns are widely used in industries due to their ability to run large amounts of samples on adaily basis. Due to this, prepacked columns dominate the chiral chromatography columns market.
Chromatography columns are critical factors to the successful separation of valuable molecules. Pharmaceutical and biotechnology companies are extending their offering of standard, custom, and prepacked columns from lab-scale to pilot and process-scale. Prepacked large-scale columns meet the needs of manufacturing with single-use technologies.
Global Leaders:
To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the chiral chromatography columnmarket.The major players in the chiral chromatography column industry are Agilent Technologies (US), Thermo Fisher Scientific(US), Waters Corporation(US), Daicel Corporation (Japan), Bio-Rad Laboratories(US), W.R.Grace & Co. (US), Merk Group(Germany), GL Sciencies(Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva(US), ES Industruies (US), and Phenomenex (US)
These players are adopting various strategies to increase their share in the chiral chromatography columnmarket.Contracts & agreements,new product launches, investments and expansions and mergers have been a widely adopted strategy by the major players in the chiral chromatography columnindustry.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435
Geographical Expansion:
North America is expected to be the largest market during the forecast period.
US and Canada are the major countries considered for the study of the chiral chromatography column market. North America has a diverse and well-established R&D infrastructure, with rapid adoption of chromatography techniques among end-user industries. North America accounted for the largest share of 37.3% of the chiral chromatography columns market in 2019. A number of factors, such as increasing drug development activities, the availability of government funding for life science R&D, high adoption of technologically advanced solutions, and a large number of ongoing clinical research studies are driving the growth of the North American chiral chromatography columns market.
No comments:
Post a Comment